121 related articles for article (PubMed ID: 38197491)
21. CircRNA_0000392 promotes colorectal cancer progression through the miR-193a-5p/PIK3R3/AKT axis.
Xu H; Liu Y; Cheng P; Wang C; Liu Y; Zhou W; Xu Y; Ji G
J Exp Clin Cancer Res; 2020 Dec; 39(1):283. PubMed ID: 33317596
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-126 functions as a tumor suppressor in colorectal cancer cells by targeting CXCR4 via the AKT and ERK1/2 signaling pathways.
Liu Y; Zhou Y; Feng X; An P; Quan X; Wang H; Ye S; Yu C; He Y; Luo H
Int J Oncol; 2014 Jan; 44(1):203-10. PubMed ID: 24189753
[TBL] [Abstract][Full Text] [Related]
23. KIFC3 Promotes Proliferation, Migration, and Invasion in Colorectal Cancer
Liao H; Zhang L; Lu S; Li W; Dong W
Front Genet; 2022; 13():848926. PubMed ID: 35812733
[No Abstract] [Full Text] [Related]
24. Expression of PRDX6 Correlates with Migration and Invasiveness of Colorectal Cancer Cells.
Huang WS; Huang CY; Hsieh MC; Kuo YH; Tung SY; Shen CH; Hsieh YY; Teng CC; Lee KC; Lee KF; Kuo HC
Cell Physiol Biochem; 2018; 51(6):2616-2630. PubMed ID: 30562740
[TBL] [Abstract][Full Text] [Related]
25. miRNA-495 suppresses proliferation and migration of colorectal cancer cells by targeting FAM83D.
Yan L; Yao J; Qiu J
Biomed Pharmacother; 2017 Dec; 96():974-981. PubMed ID: 29221726
[TBL] [Abstract][Full Text] [Related]
26. EXOSC5 as a Novel Prognostic Marker Promotes Proliferation of Colorectal Cancer via Activating the ERK and AKT Pathways.
Pan H; Pan J; Song S; Ji L; Lv H; Yang Z
Front Oncol; 2019; 9():643. PubMed ID: 31380280
[No Abstract] [Full Text] [Related]
27. Upregulation of SNTB1 correlates with poor prognosis and promotes cell growth by negative regulating PKN2 in colorectal cancer.
Liu L; Chen Y; Lin X; Wu M; Li J; Xie Q; Sferra TJ; Han Y; Liu H; Cao L; Yao M; Peng J; Shen A
Cancer Cell Int; 2021 Oct; 21(1):547. PubMed ID: 34663329
[TBL] [Abstract][Full Text] [Related]
28. Atractylenolide I inhibits colorectal cancer cell proliferation by affecting metabolism and stemness via AKT/mTOR signaling.
Wang K; Huang W; Sang X; Wu X; Shan Q; Tang D; Xu X; Cao G
Phytomedicine; 2020 Mar; 68():153191. PubMed ID: 32135457
[TBL] [Abstract][Full Text] [Related]
29. IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways.
Duan S; Huang W; Liu X; Liu X; Chen N; Xu Q; Hu Y; Song W; Zhou J
J Exp Clin Cancer Res; 2018 Dec; 37(1):304. PubMed ID: 30518405
[TBL] [Abstract][Full Text] [Related]
30. STIP1 knockdown suppresses colorectal cancer cell proliferation, migration and invasion by inhibiting STAT3 pathway.
Xia Y; Chen J; Liu G; Huang W; Wei X; Wei Z; He Y
Chem Biol Interact; 2021 May; 341():109446. PubMed ID: 33766539
[TBL] [Abstract][Full Text] [Related]
31. CWH43 Is a Novel Tumor Suppressor Gene with Negative Regulation of TTK in Colorectal Cancer.
Lee CC; Tsai KY; Lee AW; Wei PL; Huang CY; Batzorig U; Chang YJ
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894942
[TBL] [Abstract][Full Text] [Related]
32. TGM3 functions as a tumor suppressor by repressing epithelial‑to‑mesenchymal transition and the PI3K/AKT signaling pathway in colorectal cancer.
Feng Y; Ji D; Huang Y; Ji B; Zhang Y; Li J; Peng W; Zhang C; Zhang D; Sun Y; Xu Z
Oncol Rep; 2020 Mar; 43(3):864-876. PubMed ID: 32020212
[TBL] [Abstract][Full Text] [Related]
33. lncRNA KCNQ1OT1 knockdown inhibits colorectal cancer cell proliferation, migration and invasiveness via the PI3K/AKT pathway.
Duan Q; Cai L; Zheng K; Cui C; Huang R; Zheng Z; Xie L; Wu C; Yu X; Yu J
Oncol Lett; 2020 Jul; 20(1):601-610. PubMed ID: 32565985
[TBL] [Abstract][Full Text] [Related]
34. BCL6B suppresses proliferation and migration of colorectal carcinoma cells through inhibition of the PI3K/AKT signaling pathway.
Gu Y; Li A; Sun H; Li X; Zha H; Zhao J; Xie J; Zeng Z; Zhou L
Int J Mol Med; 2018 May; 41(5):2660-2668. PubMed ID: 29393377
[TBL] [Abstract][Full Text] [Related]
35. ZNF280A Promotes Proliferation and Tumorigenicity via Inactivating the Hippo-Signaling Pathway in Colorectal Cancer.
Wang X; Sun D; Tai J; Chen S; Hong S; Wang L
Mol Ther Oncolytics; 2019 Mar; 12():204-213. PubMed ID: 30847384
[TBL] [Abstract][Full Text] [Related]
36. Granulin epithelin precursor promotes colorectal carcinogenesis by activating MARK/ERK pathway.
Pan Y; Cheung ST; Tong JHM; Tin KY; Kang W; Lung RWM; Wu F; Li H; Ng SSM; Mak TWC; To KF; Chan AWH
J Transl Med; 2018 Jun; 16(1):150. PubMed ID: 29866109
[TBL] [Abstract][Full Text] [Related]
37. NUCKS1 promotes the progression of colorectal cancer via activating PI3K/AKT/mTOR signaling pathway.
Zhu LL; Shi JJ; Guo YD; Yang C; Wang RL; Li SS; Gan DX; Ma PX; Li JQ; Su HC
Neoplasma; 2023 Apr; 70(2):272-286. PubMed ID: 37226932
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-493-5p suppresses colorectal cancer progression via the PI3K-Akt-FoxO3a signaling pathway.
Cui FC; Chen Y; Wu XY; Hu M; Qin WS
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4212-4223. PubMed ID: 32373957
[TBL] [Abstract][Full Text] [Related]
39. PGM1 suppresses colorectal cancer cell migration and invasion by regulating the PI3K/AKT pathway.
Zheng Z; Zhang X; Bai J; Long L; Liu D; Zhou Y
Cancer Cell Int; 2022 May; 22(1):201. PubMed ID: 35614441
[TBL] [Abstract][Full Text] [Related]
40. miRNA-708 functions as a tumor suppressor in colorectal cancer by targeting ZEB1 through Akt/mTOR signaling pathway.
Sun S; Hang T; Zhang B; Zhu L; Wu Y; Lv X; Huang Q; Yao H
Am J Transl Res; 2019; 11(9):5338-5356. PubMed ID: 31632515
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
